Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
531.2 USD | -0.52% | -0.20% | +12.79% |
Apr. 26 | HCA beats first-quarter profit estimates on higher patient admissions | RE |
Apr. 25 | Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 172B | Sales 2025 * | 182B | Capitalization | 124B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B | Net income 2025 * | 9.06B | EV / Sales 2024 * | 0.82 x |
Net Debt 2024 * | 17.19B | Net Debt 2025 * | 12.73B | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
15.5
x | P/E ratio 2025 * |
13.6
x | Employees | 104,900 |
Yield 2024 * |
1.17% | Yield 2025 * |
1.26% | Free-Float | 99.55% |
Latest transcript on Elevance Health, Inc.
1 day | -0.89% | ||
1 week | -0.80% | ||
Current month | +1.95% | ||
1 month | +2.46% | ||
3 months | +7.38% | ||
6 months | +18.00% | ||
Current year | +12.11% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 18 M€ | +4.21% | - | |
2.36% | 1,026 M€ | +6.77% | - | |
2.07% | 8 M€ | +2.44% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 532.3 | -0.31% | 298 139 |
24-04-29 | 534 | -0.61% | 644,157 |
24-04-26 | 537.3 | -0.45% | 700,726 |
24-04-25 | 539.7 | +1.11% | 1,066,975 |
24-04-24 | 533.7 | +0.15% | 916,012 |
Delayed Quote Nyse, April 30, 2024 at 10:46 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.11% | 124B | |
-8.10% | 450B | |
+19.15% | 101B | |
-1.27% | 39.4B | |
-33.50% | 36.53B | |
-5.50% | 20.15B | |
-12.48% | 3.13B | |
-40.53% | 969M | |
-32.06% | 334M |
- Stock Market
- Equities
- ELV Stock